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ABSTRACT
The ATP-binding cassette (ABC)-transporters ABCG5 and ABCG8 have been
shown to mediate hepatic and intestinal excretion of cholesterol. In various
(genetically-modified) mouse models, a strong relationship between hepatic
expression levels of Abcg5/Abcg8 and biliary cholesterol content was found. The
aim of our study was to relate hepatic expression levels of ABCG5 and ABCG8 to
biliary excretion of cholesterol in man. From 24 liver transplant patients, bile
samples were collected daily after transplantation over a 2-week period to deter-
mine bile composition. ABCG5, ABCG8, MDR3 and BSEP expression was asses-
sed by real time PCR in liver biopsies collected before and after transplantation.
Hepatic ABCG5, ABCG8 and MDR3 mRNA levels were strongly correlated. After
transplantation, the biliary secretion rate of cholesterol continuously increased,
coinciding with gradual increases in bile salt and phospholipid secretion. In con-
trast, hepatic mRNA levels of ABCG5 and ABCG8 remained unchanged in time.
Surprisingly, no correlation was found between the hepatic expression of ABCG5
and ABCG8 and biliary cholesterol secretion rates, normalized for biliary phos-
pholipid secretion. As expected, biliary phospholipid concentration correlated
well with MDR3 expression. In conclusion, the strong relationship between
ABCG5 and ABCG8 gene expression is consistent with the coordinate regulation
of both genes, and in line with heterodimerization of both proteins into a func-
tional transporter. Our results indicate that, at least during the early phase after
transplantation, hepatic ABCG5/ABCG8 expression is not directly related to bilia-
ry cholesterol secretion in humans. This suggests the existence of alternative






































































Cholesterol is critical in human metabolism. It serves as a precursor of steroid
hormones and bile salts and as a fundamental structural constituent of (intra)
cellular membranes. The intestine and liver play important roles in the mainte-
nance of cholesterol homeostasis 
(1)
. Cholesterol is acquired through intestinal
absorption from dietary sources and through endogenous synthesis from acetyl-
CoA, which mainly occurs in the liver 
(2)
. In the liver, cholesterol is redistributed
via the circulation after its incorporation into very low density lipoproteins
(VLDL), or secreted into the bile after conversion into bile salts or as free cho-
lesterol 
(2)
. The molecular mechanisms that are involved in the hepatobiliary
secretion of cholesterol have been studied extensively 
(3,4)
. Recently, it was shown
that adenosine triphosphate (ATP)-binding cassette (ABC) transporters, i.e.
ABCG5 and ABCG8, are strongly involved in this process 
(5,6)
. The genes encoding
these proteins are highly expressed in the liver and intestine of mice and man
(7;8)
. Mutations in either of the two genes encoding these ABC transporters under-
lie the autosomal recessive disease sitosterolemia 
(7,9,10)
. Affected subjects show
strongly increased intestinal absorption of dietary plant sterols (e.g., sitosterol)
and of cholesterol, and impaired biliary sterol output. This disorder is characte-
rized by markedly elevated plasma plant sterol concentrations, development of
premature atherosclerosis and depositions of sterols in tendons and skin 
(11-13)
. A
large body of evidence indicates that ABCG5 and ABCG8 are half-transporters
that dimerize to generate a functional protein 
(7,14)
. In a polarized rat hepatoma
cell line, Graf et al. 
(14)
showed that ABCG5 and ABCG8 co-localize at the canali-
cular membrane and presented evidence that both dimerization partners are
required for their trafficking to the apical cell surface. Disruption of both genes,
simultaneously or individually, in mice leads to extremely low biliary cholesterol
concentrations 
(6,15,16)
. Reversely, pharmacological induction of endogenous muri-
ne Abcg5 and Abcg8 
(17,18)
, and overexpression of human ABCG5 and ABCG8 in
transgenic mice 
(5)
, significantly promotes hepatobiliary cholesterol excretion.
Transcription of Abcg5 and Abcg8 is induced upon activation of the nuclear hor-
mone receptor liver X receptor (LXR) 
(18)
. Treatment of wild-type mice with a LXR
agonist increased Abcg5/g8 expression and secretion of cholesterol into bile 
(17,18)
and LXR knock-out mice fail to increase Abcg5/g8 expression in response to cho-
lesterol feeding 
(19)
. Kosters et al. 
(20)
found a strong linear correlation between
hepatic Abcg5 and Abcg8 gene expression levels and biliary cholesterol secreti-
on across a number of (genetically-modified) mouse models with either decrea-





) mice, biliary cholesterol levels were ~50% of those in wild-type anim-
als 
(6)






. In mice expressing up to 16 copy numbers of both
genes, a significant positive linear relationship between Abcg5/Abcg8 mRNA
levels and biliary cholesterol concentrations was also observed 
(21)
. Reduced
Abcg5 and Abcg8 expression in livers of streptozotocin-diabetic rats was associ-
ated with reduced biliary cholesterol content 
(22)
. Together, these studies esta-
blished strong relationships between hepatic Abcg5/Abcg8 mRNA levels and bili-
ary cholesterol output in rodents, indicative for a high degree of control exerted
by the transporter pair. 
In the present study, we examined the relationship between hepatic ABCG5 and
ABCG8 expression and biliary cholesterol output in patients after successful
orthotopic liver transplantation (OLT). Surprisingly, our data demonstrate that, in
this specific patient population, there is no direct relationship between





































































Patients and tissue specimens
Liver tissue specimens were obtained during routine diagnostic biopsies from 24
grafts. According to the Groningen liver transplant protocol, three consecutive
needle biopsies were collected: at the end of cold preservation, approximately 3
hours after reperfusion and 1 week after transplantation. An aliquot of the bio-
psy specimen was immediately snap-frozen in liquid nitrogen for isolation of total
RNA. The remaining material was used for routine histological analysis. Before
transplantation, the gallbladder was removed from the donor liver. During the
transplantation, after revascularization of the graft, a catheter was inserted in
the common bile duct in accordance with our protocol. Via this open biliary tube,
bile flow was entirely diverted outside the patient into a collection bag that was
placed below the horizontal bed level 
(23)
. Interruption of the enterohepatic circu-
lation in the patient was prevented through readministration of bile in the small
intestine via a percutaneous feeding jejunostomy catheter. Bile samples were
collected daily in the first postoperative week, and were collected three times in
the second week. Bile was collected between 8 and 9 am for measurements of
total bile salt, phospholipid and cholesterol concentration. Bile volume was asses-
sed gravimetrically. Postoperative immunosuppression was based on tacrolimus
or cyclosporin and a rapid taper of steroids. Donor and recipient demographics
and surgical variables are listed in Table 1. Normal liver tissue (n=5) was collec-
ted from resections for tumors. Patients had given written informed consent
before sampling of tissue specimens. All liver biopsies and bile samples were sto-
red at -80°C.
Bile analysis
Bile was analyzed for total bile salt, phospholipid and cholesterol contents. Total
bile salt concentrations were measured spectrofotometrically with 3α-hydroxys-
teroid dehydrogenase 
(24)
. Bile salt composition was analyzed by capillary
gaschromatography as described earlier 
(25)
. The hydrophobicity index of indivi-
dual bile salts was calculated using indices described by Heuman et al. 
(26)
and
using estimated 3:1 glycine/taurine bile salt conjugation ratio. Phospholipid con-
centrations in bile were assayed using a commercially available enzymatic
method (Wako Chemicals GmbH, Neuss, Germany). Biliary cholesterol concen-
trations were determined enzymatically with cholesterol oxidase (Roche




































































measured daily to calculate bile flow. Bile flow was expressed as daily bile pro-
duction per kg body weight of the donor.
RNA extraction and reverse-transcriptase polymerase chain reaction
Isolation of total RNA was performed using TRIzol (Invitrogen Life Technologies,
Breda, the Netherlands) and quantified using Ribogreen (Molecular Probes, Inc.,
Eugene, OR, USA) according to manufacturer's instructions. Reverse transcripti-
on was performed on 3.36 µg RNA using random primers in a final volume of 75
µl (Reverse Transcription System, Promega, Madison, WI, USA). mRNA levels of
ATP-binding cassette transporter A1 (ABCA1), the multidrug resistance protein 3
(MDR3; gene symbol ABCB4), the bile salt export pump (BSEP; gene symbol
ABCB11), ABCG5, ABCG8 and the scavenger receptor class B type I (SR-BI) were
measured by real-time polymerase chain reaction (PCR) using the ABI PRISM
7700 sequence detector (Applied Biosystems, Foster City, CA, USA). 18S rRNA
expression values were used as reference. Nucleotide sequences of the primers
Table 1. Demographic data of donors and recipients and surgical variables (n=24).
Donor variables
Age (years; mean [range]) 43 (17-66)
Gender (M/F) 7/17
Causes of death (number [%])





Age (years; mean [range]) 41 (18-60)
Gender (M/F) 12/12
Disease (number [%])
Postnecrotic cirrhosis 15 (63%)
Hepatitis C virus 4
Hepatitis B virus 3
Autoimmune hepatitis 3
Liver cirrhosis n.o.s. 3
Alcoholic liver cirrhosis 2
Biliary cirrhosis 5 (21%)
Primary sclerosing cholangitis 2
Primary biliary cirrhosis 2
Biliary liver cirrhosis 1
Metabolic disorder 2 (8%)






Cold Ischemia Time, CIT (minutes; mean ± SEM) 522 (±27)
Warm Ischemia Time, WIT (minutes; mean ± SEM) 45 (±2)
Abbreviations: CIT, time between start cold perfusion in the donor and end of cold preservation of the liver graft;
WIT, time between the end of cold ischemic preservation of the liver and start of reperfusion in the recipient.




































































(Invitrogen, Paisley, Scotland) and probes (Eurogentec, Herstal, Belgium) were
designed using Primer Express software (PE Applied Biosystems). Probes were 5'
labeled by a 6-carboxy-fluorescein (FAM) reporter and 3' labeled with a 6-car-
boxy-tetramethyl-rhodamine (TAMRA) quencher, and are listed in Table 2. In
each PCR reaction, duplicate samples of 4 µl cDNA (20x) were used in a final
volume of 20 µl, containing 900 nmol/l sense and antisense primers, 200 nmol/l
probe, 5 mmol/l MgCl2, 0.2 mmol/l dNTP's, 2 µl Real-Time PCR buffer (10x), and
0.5 U Hot Goldstar DNA polymerase (qPCR Core Kit, Eurogentec, Seraing,
Belgium).        
Statistical analysis
Statistics were performed using SPSS Version 12.0 for Windows (SPSS Inc.,
Chicago, IL, USA). All data are expressed as mean values and standard error of
the mean (SEM). Differences were analyzed using the Mann Whitney U-test,
Pearson Correlation-test and Wilcoxon Signed Rank-test where appropriate. P-
values were 2-tailed and statistically significant at a level of < 0.05.  
Alernative GenBank PCR
Gene name Primers and probes accession no. product (bp) Reference
ABCA1 ABC1 sense 5'-CCC AGA GCA AAA AGC GAC TC-3' NM_005502 101
antisense 5'-GGT CAT CAT CAC TTT GGT CCT TG-3'
probe 5' FAM-AGA CTA CTC TGT TTC TCA GAC AAC ACT TGA CCA AGT- TAMRA 3'
ABCB4 MDR3 sense 5'-TCA ATG GCT TTT AAA GCA ATG CTA-3' XM_167466 143 (27)
antisense 5'-TGC AAT TAA AGC CAA CCT GGT T-3'
probe 5' FAM-CAC AGA TGC TGC CCA AGT CCA AGG A- TAMRA 3'
ABCB11 BSEP sense 5'-ACA TGC TTG CGA GGA CCT TTA-3' XM_002644 105 (27)
antisense 5'-GGA GGT TCG TGC ACC AGG TA-3'
probe 5' FAM-CCA TCC GGC AAC GCT CCA AGT CT- TAMRA 3'
ABCG5 White3 sense 5'-TCT CTT GGC CCC CCA CTT A-3' NM_022436 73 (28)
Sterolin1 antisense 5'-CTA TAT TTG GAT TTT GGA CGA TAC CA-3'
probe 5' FAM-TTG GTG AAT TTC TAA CTC TTG TGC T- TAMRA 3'
ABCG8 White4 sense 5'-GAC AGC TTC ACA GCC CAC AA-3' NM_022437 105 (17)
Sterolin2 antisense 5'-GCC TGA AGA TGT CAG AGC GA-3'
probe 5' FAM-CTG GTG CTC ATC TCC CTC CAC CAG- TAMRA 3'
SR-BI Scarb1 sense 5'-GTC GCA GGC ATT GGA CAA AC-3' NM_005505 71
antisense 5'-CCG CTC TCT GCA AAC CAG AG-3'
probe 5' FAM-CGG CAG GAC CAC AGG CTC AAT CTT C- TAMRA 3'
18S sense 5'-CGG CTA CCA CAT CCA AGG A-3' X03205 109 (27)
antisense 5'-CCA ATT ACA GGG CCT CGA AA-3'
probe 5' FAM-CGC GCA AAT TAC CCA CTC CCG A- TAMRA 3'
 

























































































































































































Figure 1. Recovery of bile flow (A), bile salt (B), phospholipid (C) and cholesterol (D) secretion rates during 14
days after liver transplantation in 24 patients, expressed as mean values ± SEM. *P-values indicate statistical sig-
nificant differences between postoperative days 1 and 7.
RESULTS
Restoration of biliary lipid secretion after successful liver
transplantation
Twenty four patients who received a liver transplant participated in this study.
Bile flow increased progressively during the first postoperative week, reflecting
adequate recovery of hepatobiliary function of the liver after transplantation
(Figure 1A). Biliary bile salt secretion, known to be the main driving force for bile
production, increased curvilinearly (Figure 1B). Concomitantly, the biliary excre-
tion rates of phospholipids and cholesterol significantly increased during the first
postoperative week (Figure 1C and D) and continued to rise during the second
week. 
When output rates of bile salts, phospholipids and cholesterol were plotted
against each other, strong positive correlations were found (Figure 2A-C), as has
been previously reported 
(29)




































































rate, no phosholipid and cholesterol secretion was observed (Figure 2A and B).
Thus, it appears that hepatobiliary lipid secretion proceeds normally under post-
transplantation conditions.
Hepatic ABCG5 and ABCG8 expression does not correlate with biliary
cholesterol secretion in liver transplant recipients
By using real time PCR, transporter mRNA levels were analyzed in control livers
and in liver grafts before transplantation, 3 hours after resuming blood circulati-
on of the transplant and one week after the operation. mRNA copy numbers of
transporter genes were normalized to those of 18S rRNA.
Liver biopsies collected one week after transplantation, were used to compare
ABCG5 and ABCG8 transporter expression levels and biliary cholesterol secreti-
on. At this time point, biliary lipid secretion was analyzed in detail.
Because of the assumption that ABCG5 and ABCG8 are half-transporters that
have to dimerize to generate a functional protein 
(7,14)
, mRNA levels of the two
genes were directly compared. Although ABCG8 mRNA expression levels were
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Figure 2. Relation between bile salt and phospholipid secretion (A), bile salt and cholesterol output (B) and phos-














































Figure 3. Relation between ABCG8 and ABCG5 mRNA levels in liver grafts before OLT (A), 3 hours after reperfu-

























Figure 4. mRNA levels of BSEP, MDR3 and ABCG5/G8 in normal control livers (n=5), and in liver grafts before OLT,
3 hours after reperfusion and 1 week after OLT (n=24). 18S rRNA was used as reference. mRNA levels were expres-
sed as mean values ± SEM. *P < 0.01, BSEP expression one week after transplantation was significantly increased




































































ABCG5 and ABCG8 mRNA levels were found at all three time points, supporting
similar mode of regulation (Figure 3A-C).
The mRNA levels of two other major transporters, the bile salt transporter BSEP
(gene symbol ABCB11) and the phospholipid translocator MDR3 (gene symbol
ABCB4), were also determined, as summarized in Figure 4. Except for minor,
non-significant changes, BSEP, MDR3, ABCG5 and ABCG8 mRNA levels in liver
transplants before operation and after 3 hours of recirculation did not differ from
expression levels in control livers. One week after transplantation, BSEP expres-
sion was significantly increased compared to control livers and liver grafts befo-
re transplantation and after reperfusion (Figure 4). MDR3, ABCG5 and ABCG8
mRNA levels at one week were unchanged compared to control values. mRNA
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ABCG8: P < 0.0001
r = 0.70
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ABCG8: P < 0.001
r = 0.64
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ABCG8: P < 0.003
r = 0.58
ABCG5: P < 0.001
r = 0.61
Figure 5. Relationship between MDR3 and ABCG5/G8 mRNA levels in liver grafts before OLT (A), 3 hours after
reperfusion (B) and 1 week after OLT (C) (n=24).
46
levels at one week: 0.28 - 3.43, 0.26 - 2.85 and 0.26 - 4.31 for MDR3, ABCG5
and ABCG8, respectively). Within individual liver grafts, mRNA levels of MDR3,
ABCG5 and ABCG8 did not change very much. Since phospholipids may drive
cholesterol secretion and MDR3 controls phospholipid output 
(30,31)
, relationships
between hepatic expression levels of ABCG5 and ABCG8 to MDR3 were analy-
zed. At all three time points, strong positive correlations between ABCG5/MDR3
and ABCG8/MDR3 expression levels were found (Figure 5A-C).
To segregate effects of phospholipid secretion on cholesterol secretion, the rati-
os of ABCG5 and ABCG8 to MDR3 expression were calculated and were plotted
as a function of the ratio of cholesterol to phospholipid excretion, as previously
shown by Kosters et al 
(20)
. In contrast with the strong positive relationship
between the normalized Abcg5 and Abcg8 values and the normalized biliary cho-
lesterol output in (genetically-modified) mice 
(20)
, we could not find such a relati-
onship in liver transplant patients (Figure 6). Also when biliary cholesterol secre-
tion was not corrected for phospholipid secretion, no relationship between
ABCG5/G8 and absolute biliary cholesterol secretion was observed (r = 0.21, P
= 0,31 and r = 0.05, P = 0.80, for ABCG5 and ABCG8, respectively). As expec-
ted, MDR3 expression correlated well with biliary phospholipid concentration (r
= 0.42, P = 0.03), but not with cholesterol concentration (r = 0.25, P = 0.21) in
the bile.
Figure 6. Phospholipid-independent relation between normalized biliary cholesterol output and hepatic ABCG5 and
ABCG8 mRNA levels one week after liver transplantation (n=24). ABCG5 and ABCG8 expression levels were nor-
malized to MDR3 mRNA levels (ABCG5/MDR3 and ABCG8/MDR3). The normalized ABCG5 and ABCG8 values were
plotted against the normalized biliary cholesterol output (cholesterol/phospholipid ratio) to determine the relation





































































































In search for an explanation for the unexpected lack of correlation between cho-
lesterol output and ABCG5/G8 expression, biliary bile salt composition was ana-
lyzed to allow calculation of the "hydrophobicity index" 
(26)
. Although, in general,
relatively hydrophobic bile salts are more effective in driving biliary cholesterol
secretion, no relationship between the hydrophobicity index and absolute or nor-
malized biliary cholesterol output was found in bile collected one week after OLT
(Figure 7).
In search for possible alternative hepatobiliary cholesterol secretion pathways,
SR-BI and ABCA1 mRNA levels were analyzed 
(32,33)
. Sehayek et al. 
(32) 
have sug-
gested that SR-BI may directly promote the excretion of cholesterol into the bile.
In transgenic mice overexpressing the human ABCA1 gene, biliary cholesterol
excretion was found to be facilitated 
(33)
. Neither SR-BI or ABCA1 expression,
however, showed any relationship with absolute or normalized biliary cholesterol
secretion at one week after liver transplantation (r = -0.19, P = 0,35 and r = -
0.16, P = 0.44, for SR-BI and ABCA1, respectively). Surprisingly, a strong linear
relationship between hepatic SR-BI and ABCA1 expression levels was observed
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Figure 7. Relation between normalized biliary cholesterol output (cholesterol/phospholipid ratio) and calculated
bile salt hydrophobicity index in 24 patients. The normalized biliary cholesterol secretion was plotted against the




In the present study we followed the recovery of bile formation after successful
human OLT and assessed the relationship between hepatic expression levels of
the ATP-binding cassette (ABC) half-transporters ABCG5/ABCG8 and hepatobili-
ary cholesterol secretion. A vast body of evidence has been generated demon-
strating that, in mice, Abcg5/Abcg8 are of crucial importance in control of bilia-
ry secretion of sterols 
(5,6,34)
. The main finding of this study is that we were not
able to detect a relationship between the normalized hepatic expression of
ABCG5 and ABCG8 and the normalized biliary output of cholesterol in humans
(Figure 5), while such a relationship is obviously present in rodents.
After transplantation, bile flow recovered gradually. Bile flow is mainly driven by
active biliary bile salt secretion 
(29)
. The recovery of bile flow therefore is likely a
consequence of normalization of the circulating bile salt pool. In parallel with the
recovery of bile salt secretion, cholesterol secretion and phospholipid output inc-
reased and were found to be tightly related to each other, as expected 
(29)
. The
observed recovery of bile flow and the relationships between biliary secretion
rates of bile salts, phospholipids and cholesterol in our study were similar to
those previously described by others 
(35,36)
.
Changes in bile formation were not associated with marked alterations in hepa-
tic transporter expression: only mRNA levels of the bile salt transporter BSEP
(gene symbol ABCB11) were slightly, but significantly increased at 1 week after
OLT compared to levels in control livers and liver grafts before transplantation
and 3 hours after reperfusion. The mRNA levels of the phospholipid translocator
MDR3 (gene symbol ABCB4) and ABCG5/G8 remained stable between the diffe-
rent time points. We could clearly demonstrate a strong positive relationship
between ABCG5 and ABCG8 expression levels at the three time points studied
(Figures 3A-C), suggesting a tight coupling between the two transporter genes
in human liver. This relation supports the concept that ABCG5 and ABCG8 are
partners in the generation of a functional transporter 
(14)
. The parallel expression
of ABCG5/G8 also supports the perception that both genes are coordinately
regulated. The nuclear receptors liver receptor homolog-1 (LRH-1) and liver X
receptor (LXR) have α been proposed as major regulatory transcription factors
for ABCG5/G8 
(37,38)
. LRH-1 and LXRα are known to regulate the expression of
many key enzymes in lipid metabolism 
(18,38)
. Using electrophoretic mobility shift
assays (EMSAs), Freeman et al. 
(38)
recently found a LRH-1-specific binding motif
in the ABCG5/G8 intergenic region. By mutating this LRH-1 binding site, a more








































































showed that ABCG5/G8 are direct target genes of the oxysterol-activated
nuclear receptor LXRα. 
Phospholipids are required for biliary cholesterol secretion. Mice lacking Mdr2
(Abcb4, the murine homologue of MDR3/ABCB4) have low or undetectable cho-
lesterol concentrations in the bile 
(6,30)
. Because of the close coupling between
cholesterol and phospholipid secretion, the ratio of cholesterol to phospholipid
secretion (normalized cholesterol output) provides a functionally relevant reflec-
tion of hepatobiliary cholesterol secretion that allows comparison between indi-
viduals 
(3)
. By comparing mice with either increased or decreased biliary choles-
terol secretion rates, a strong positive relationship was found between the nor-
malized biliary cholesterol output and the normalized Abcg5/g8 expression levels
(20)




) mice, it was found that bili-
ary cholesterol levels were about 50% compared to those in wild-type animals
(6)
, which represents the most convincing evidence for a high degree of control
strength of Abcg5/g8 in the process of hepatobiliary cholesterol secretion.
Surprisingly, in the patient population studied, a relationship between hepatic
ABCG5/G8 gene expression levels and biliary cholesterol output was completely
absent. Unfortunately, the amount of tissue available did not allow for quantifi-
cation of ABCG5/G8 protein levels by means of Western blotting 
(39,40)
. Possible
post-transcriptional events leading to modifications in ABCG5/G8 protein expres-
sion can therefore not be excluded. 
Because human bile salts, in general, are more hydrophobic than murine bile
salts and hydrophobic bile salts drive cholesterol output more effectively, the
"hydrophobicity index" was calculated in an attempt to explain the lack of corre-
lation between ABCG5/G8 and biliary cholesterol output 
(26)
. When corrected for
the biliary hydrophobicity index, however, also no relationship could be found.
We speculate that, in humans the actual canalicular transport step may be
mediated by ABCG5/G8, but that this step is not rate-controlling in the overall
process. Alternatively, it may be that in humans alternative, ABCG5/G8-indepen-
dent processes are involved. In mice fed a diosgenin-containing diet, causing a
dramatic ~15-fold increase in biliary cholesterol secretion, Kosters et al.
(20) 
obser-
ved that hepatic Abcg5/g8 expression levels remained unaffected. By determina-
tion of the flux control coefficient (FCC) of murine Abcg8, they could demonstra-
te that the rate control by Abcg8 in mediating biliary cholesterol efflux was limi-
ted 
(41)
. FCC values of Abcg8 in mice varied from 50% at low cholesterol secreti-




. Yu et al. 
(21) 
sub-
sequently, confirmed that diosgenin feeding in mice increases biliary cholesterol
concentrations without changing hepatic Abcg5/g8 mRNA and protein levels.
50
These authors also confirmed that the presence of Abcg5 and Abcg8 is required
for the stimulatory effect of diosgenin 
(21)
, as was shown earlier by Kosters et al.
(41)
who demonstrated an absence of an increase in biliary cholesterol secretion
in diosgenin-treated Abcg8
-/-
mice. The nuclear receptor pregnane X receptor
(PXR) may be the mediator of diosgenin-induced biliary hypersecretion of cho-
lesterol. In rats, the PXR ligand pregnenolone-16α-carbonitrile has been shown
to increase biliary cholesterol secretion 
(42)
. Increases in biliary cholesterol con-





Biliary cholesterol secretion therefore might be facilitated by certain PXR target
genes 
(21)
, that may be involved in modulation of the activity of Abcg5/g8 trans-
porters or may constitute an alternative pathway of canalicular cholesterol excre-
tion.
The scavenger receptor class B type I (SR-BI) has been suggested to modulate
cholesterol secretion into bile 
(32)





showed a respectively, reduced and markedly enhanced biliary choleste-
rol secretion. SR-BI is known to play a role in selective high density lipoprotein
(HDL) cholesterol uptake at the basolateral hepatocyte membrane, but Sehayek
et al. 
(32)
hypothesized that SR-BI may also be directly involved in biliary choles-
terol secretion. We, however, did not observe any correlation between SR-BI
mRNA levels and cholesterol secretion into the bile, indicating no rate-controlling
function for SR-BI in hepatobiliary cholesterol flux in humans. Finally, although
hepatobiliary cholesterol secretion has been shown to be facilitated in transge-
nic mice overexpressing human ABCA1 
(33)
, we found no correlation between
hepatic ABCA1 mRNA levels and biliary cholesterol secretion. We did find an
extremely strong correlation between hepatic SR-BI and ABCA1 mRNA levels,
suggesting a coordinate regulation of both genes that are crucial in (hepatic)
HDL metabolism. The nature of this regulation, indicative for a functional link
between selective HDL cholesterol uptake and pre-βHDL formation, is currently
under investigation.




mice the biliary cholesterol
levels are extremely low compared to normal wild type mice 
(6)
, the secretion of
cholesterol and other sterols in bile is reduced by only ~50% in patients with
sitosterolemia compared to healthy individuals 
(46)
. The residual biliary sterol
secretion in sitosterolemic patients 
(46)
, and the absence of any relationship
between hepatic ABCG5/G8 expression and biliary cholesterol secretion in our
study, supports the notion that additional transport mechanisms may operate in
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